Michael S Wyzga - Net Worth and Insider Trading
Michael S Wyzga Net Worth
The estimated net worth of Michael S Wyzga is at least $235,249 dollars as of 2024-09-20. Michael S Wyzga is the Director of Exact Sciences Corp and owns about 2,558 shares of Exact Sciences Corp (EXAS) stock worth over $181,183. Michael S Wyzga is also the Director of X4 Pharmaceuticals Inc and owns about 76,667 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $54,066. Details can be seen in Michael S Wyzga's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael S Wyzga has not made any transactions after 2023-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael S Wyzga
Michael S Wyzga Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael S Wyzga owns 7 companies in total, including Exact Sciences Corp (EXAS) , LogicBio Therapeutics Inc (LOGC) , and X4 Pharmaceuticals Inc (XFOR) among others .
Click here to see the complete history of Michael S Wyzga’s form 4 insider trades.
Insider Ownership Summary of Michael S Wyzga
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EXAS | Exact Sciences Corp | 2021-02-26 | director |
LOGC | LogicBio Therapeutics Inc | 2018-10-18 | director |
XFOR | X4 Pharmaceuticals Inc | 2023-08-18 | director |
2018-06-22 | director | ||
2014-03-19 | director | ||
2011-12-05 | director & Chief Executive Officer | ||
2022-06-22 | director |
Michael S Wyzga Latest Holdings Summary
Michael S Wyzga currently owns a total of 2 stocks. Among these stocks, Michael S Wyzga owns 2,558 shares of Exact Sciences Corp (EXAS) as of February 26, 2021, with a value of $181,183 and a weighting of 77.02%. Michael S Wyzga also owns 76,667 shares of X4 Pharmaceuticals Inc (XFOR) as of August 18, 2023, with a value of $54,066 and a weighting of 22.98%.
Latest Holdings of Michael S Wyzga
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EXAS | Exact Sciences Corp | 2021-02-26 | 2,558 | 70.83 | 181,183 |
XFOR | X4 Pharmaceuticals Inc | 2023-08-18 | 76,667 | 0.71 | 54,066 |
Holding Weightings of Michael S Wyzga
Michael S Wyzga Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael S Wyzga has made a total of 1 transactions in Exact Sciences Corp (EXAS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Exact Sciences Corp is the sale of 19,021 shares on February 26, 2021, which brought Michael S Wyzga around $2 Million.
According to the SEC Form 4 filings, Michael S Wyzga has made a total of 1 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in X4 Pharmaceuticals Inc is the acquisition of 25,000 shares on August 18, 2023, which cost Michael S Wyzga around $30,000.
Insider Trading History of Michael S Wyzga
- 1
Michael S Wyzga Trading Performance
GuruFocus tracks the stock performance after each of Michael S Wyzga's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael S Wyzga is -31.35%. GuruFocus also compares Michael S Wyzga's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael S Wyzga within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael S Wyzga's insider trading performs compared to the benchmark.
Performance of Michael S Wyzga
Michael S Wyzga Ownership Network
Michael S Wyzga Owned Company Details
What does Exact Sciences Corp do?
Who are the key executives at Exact Sciences Corp?
Michael S Wyzga is the director of Exact Sciences Corp. Other key executives at Exact Sciences Corp include Gen. Mgr. & Precision Oncology Brian Baranick , General Counsel James Herriott , and director & Vice President Kevin T Conroy .
Exact Sciences Corp (EXAS) Insider Trades Summary
Over the past 18 months, Michael S Wyzga made no insider transaction in Exact Sciences Corp (EXAS). Other recent insider transactions involving Exact Sciences Corp (EXAS) include a net sale of 28,371 shares made by Sarah Condella , a net sale of 10,530 shares made by Brian Baranick , and a net sale of 6,703 shares made by James Herriott .
In summary, during the past 3 months, insiders sold 929 shares of Exact Sciences Corp (EXAS) in total and bought 0 shares, with a net sale of 929 shares. During the past 18 months, 183,810 shares of Exact Sciences Corp (EXAS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 183,810 shares.
Exact Sciences Corp (EXAS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Exact Sciences Corp Insider Transactions
Michael S Wyzga Mailing Address
Above is the net worth, insider trading, and ownership report for Michael S Wyzga. You might contact Michael S Wyzga via mailing address: Radius Health, Inc., 201 Broadway, 6th Floor, Cambridge Ma 02139.